© 2003 by BMJ Publishing Group & British Cardiac Society
JournalScan
JournalScan
| The first 150 words of the full text of this article appear below. |
Ischaemic heart disease

One hundred and sixty patients with type 2 diabetes and microalbuminuria were randomly assigned to receive conventional care or intensive treatment. Patients in the intensive therapy group were treated with drugs to maintain glycosylated haemoglobin values below 6.5%, blood pressure below 130/80 mm Hg, cholesterol below 4.5 mmol/l, and triglyceride below 1.7 mmol/l. Recommended lifestyle interventions included reduced dietary fat, regular moderate exercise, and cessation of smoking. All participants in the intensive therapy group were also advised to take aspirin and a dietary supplement that included vitamins E and C, folic acid, and chrome picolinate. In addition, patients in the intensive therapy group were given an angiotensin converting enzyme (ACE) inhibitor (or, if contraindicated, an angiotensin II receptor antagonist), regardless of blood pressure, to slow the progression of renal disease. After a mean follow up of 7.8 years, one or more cardiovascular events (death from cardiovascular causes, non-fatal myocardial infarction
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
